PL Lodz Watala C: Difference between revisions
From Bioblast
No edit summary |
Marte Verena (talk | contribs) No edit summary |
||
| Line 11: | Line 11: | ||
|MiPNetLab=Labieniec-Watala M, Dudzinska D, Novak J, Siewiera K | |MiPNetLab=Labieniec-Watala M, Dudzinska D, Novak J, Siewiera K | ||
|Status=O2k 2010- | |Status=O2k 2010- | ||
|info=[[Bioblast 2012]], [[IOC61]], [http://www.oroboros.at/?IOC55-56 IOC55-56] | |info=[[Bioblast 2012]], [http://www.oroboros.at/index.php?id=ioc72 IOC72], [[IOC61]], [http://www.oroboros.at/?IOC55-56 IOC55-56] | ||
}} | }} | ||
== Areas of interest == | == Areas of interest == | ||
Revision as of 15:30, 10 October 2013
Areas of interest
- Mitochondrial respiratory capacity under normal and pathophysiological conditions (diabetes mellitus, atherothrombosis, brain-blood barrier disruption, cancerogenesis)
- Pharmacological modulation of mitochondrial function by selected pharmaceuticals of anti-diabetic activity
- Targeting of biochemical and molecular burden of diabetes
Gentle Science
- Link to Gentle Science.
